These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36104931)

  • 41. On Robustness of Individualized Decision Rules.
    Qi Z; Pang JS; Liu Y
    J Am Stat Assoc; 2023; 118(543):2143-2157. PubMed ID: 38143785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On using electronic health records to improve optimal treatment rules in randomized trials.
    Wu P; Zeng D; Fu H; Wang Y
    Biometrics; 2020 Dec; 76(4):1075-1086. PubMed ID: 32365232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Robust and efficient semi-supervised estimation of average treatment effects with application to electronic health records data.
    Cheng D; Ananthakrishnan AN; Cai T
    Biometrics; 2021 Jun; 77(2):413-423. PubMed ID: 32413171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tree-based Ensemble Methods For Individualized Treatment Rules.
    Zhu K; Huang Y; Zhou XH
    Biostat Epidemiol; 2017; 2(1):61-83. PubMed ID: 31650095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Privacy-preserving estimation of an optimal individualized treatment rule: a case study in maximizing time to severe depression-related outcomes.
    Moodie EEM; Coulombe J; Danieli C; Renoux C; Shortreed SM
    Lifetime Data Anal; 2022 Jul; 28(3):512-542. PubMed ID: 35499604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation and Optimization of Composite Outcomes.
    Luckett DJ; Laber EB; Kim S; Kosorok MR
    J Mach Learn Res; 2021 Jan; 22():. PubMed ID: 34733120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Minimum clinically important difference in medical studies.
    Hedayat AS; Wang J; Xu T
    Biometrics; 2015 Mar; 71(1):33-41. PubMed ID: 25327276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome weighted
    Liu M; Shen X; Pan W
    Stat; 2020 Dec; 10(1):. PubMed ID: 34937955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimation and inference on high-dimensional individualized treatment rule in observational data using split-and-pooled de-correlated score.
    Liang M; Choi YG; Ning Y; Smith MA; Zhao YQ
    J Mach Learn Res; 2022; 23():. PubMed ID: 38098839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Weighted Fuzzy Interpolative Reasoning Based on the Slopes of Fuzzy Sets and Particle Swarm Optimization Techniques.
    Chen SM; Hsin WC
    IEEE Trans Cybern; 2015 Jul; 45(7):1250-61. PubMed ID: 25204003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.
    Shen J; Wang L; Daignault S; Spratt DE; Morgan TM; Taylor JMG
    J Biopharm Stat; 2018; 28(2):362-381. PubMed ID: 28934002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intervention treatment distributions that depend on the observed treatment process and model double robustness in causal survival analysis.
    Wen L; Marcus JL; Young JG
    Stat Methods Med Res; 2023 Mar; 32(3):509-523. PubMed ID: 36597699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach.
    Bennett CC; Hauser K
    Artif Intell Med; 2013 Jan; 57(1):9-19. PubMed ID: 23287490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative contrast estimation and inference for treatment recommendation.
    Liang M; Yu M
    Biometrics; 2023 Dec; 79(4):2920-2932. PubMed ID: 36645310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robust method for optimal treatment decision making based on survival data.
    Fang Y; Zhang B; Zhang M
    Stat Med; 2021 Dec; 40(29):6558-6576. PubMed ID: 34549828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted learning ensembles for optimal individualized treatment rules with time-to-event outcomes.
    Díaz I; Savenkov O; Ballman K
    Biometrika; 2018 Sep; 105(3):723-738. PubMed ID: 30799874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A general framework for subgroup detection via one-step value difference estimation.
    Johnson D; Lu W; Davidian M
    Biometrics; 2023 Sep; 79(3):2116-2126. PubMed ID: 35793474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine.
    Arora P; Boyne D; Slater JJ; Gupta A; Brenner DR; Druzdzel MJ
    Value Health; 2019 Apr; 22(4):439-445. PubMed ID: 30975395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicategory Outcome Weighted Margin-based Learning for Estimating Individualized Treatment Rules.
    Zhang C; Chen J; Fu H; He X; Zhao YQ; Liu Y
    Stat Sin; 2020; 30():1857-1879. PubMed ID: 33311956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.